Male Patients with Cancer at Higher Risk of Severe Disease Course and Mortality Attributable to COVID-19
Findings from a systematic review and meta-analysis
Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
Make sure you check these pages frequently, or sign up to our newsletter! To sign up for ESMO newsletters, create a myESMO account here and select the newsletters you’d like to receive.
Findings from a systematic review and meta-analysis
Findings from the CheckMate 205 study
The efficacy was evaluated in CANDOR and EQUULEUS trials
Final overall survival results from the EMBRACA trial
Findings from a large regional analysis of population that examined the prevalence of cancer and clinical outcomes of viral infection
Evaluation of population level mortality trends attributed to specific subtypes of lung cancer
The findings from the VIALE-A study
Findings from a large testing study conducted at a tertiary care hospital in Vienna
It was evaluated in DREAMM-2 study
It was intended for the treatment of blastic plasmacytoid dendritic cell neoplasm
The results of INSPIRE study
Results of the NCI-MATCH Trial Subprotocol H
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.